CA Stock MarketDetailed Quotes

RKV Rakovina Therapeutics Inc

Watchlist
  • 0.165
  • -0.020-10.81%
15min DelayMarket Closed Jan 7 16:00 ET
14.90MMarket Cap-4.13P/E (TTM)

Rakovina Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
60.47%947.21K
29.22%755.97K
6.92%690.07K
-11.90%2.48M
1.31%661.44K
-18.85%590.27K
-19.17%585.01K
-9.55%645.39K
13.87%2.82M
-13.15%652.86K
Selling and administrative expenses
64.55%268.91K
43.07%276.18K
18.41%251.09K
-6.66%810.42K
55.96%241.93K
-8.70%163.42K
-30.63%193.04K
-15.21%212.04K
-10.66%868.28K
-44.18%155.12K
-General and administrative expense
64.55%268.91K
43.07%276.18K
18.41%251.09K
-6.66%810.42K
55.96%241.93K
-8.70%163.42K
-30.63%193.04K
-15.21%212.04K
-10.66%868.28K
-44.18%155.12K
Research and development costs
58.91%678.3K
22.40%479.79K
1.30%438.98K
-14.24%1.67M
-15.72%419.51K
-22.16%426.85K
-12.00%391.97K
-6.50%433.34K
29.74%1.95M
5.05%497.74K
Operating profit
-60.47%-947.21K
-29.22%-755.97K
-6.92%-690.07K
11.90%-2.48M
-1.31%-661.44K
18.85%-590.27K
19.17%-585.01K
9.55%-645.39K
-13.87%-2.82M
13.15%-652.86K
Net non-operating interest income (expenses)
-19.94%-67.99K
-321.08%-64.39K
-1,605.63%-61.26K
-556.02%-128.94K
-948.55%-61.04K
-641.16%-56.68K
-301.41%-15.29K
34.91%4.07K
231.13%28.28K
153.63%7.19K
Non-operating interest income
--0
-73.37%1.84K
-2.14%3.98K
-20.88%22.37K
-44.71%3.98K
-29.11%7.43K
-9.13%6.9K
34.91%4.07K
231.13%28.28K
153.63%7.19K
Non-operating interest expense
6.05%67.99K
198.44%66.22K
--65.25K
--151.31K
--65.01K
--64.11K
--22.19K
--0
--0
--0
Other net income (expenses)
-2,389.47%-473
79.77%-224
-121.61%-1.05K
7.14%-1.89K
83.69%-287
-101.91%-19
-809.62%-1.11K
66.81%-472
99.93%-2.03K
29.12%-1.76K
Gain on sale of security
-2,389.47%-473
79.77%-224
-121.61%-1.05K
7.14%-1.89K
83.69%-287
-101.91%-19
-809.62%-1.11K
66.81%-472
45.74%-2.03K
29.12%-1.76K
Income before tax
-56.99%-1.02M
-36.44%-820.58K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
9.63%-646.97K
16.00%-601.4K
9.86%-641.79K
49.44%-2.79M
13.83%-647.43K
Income tax
Earnings from equity interest net of tax
Net income
-56.99%-1.02M
-36.44%-820.58K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
9.63%-646.97K
16.00%-601.4K
9.86%-641.79K
49.44%-2.79M
13.83%-647.43K
Net income continuous operations
-56.99%-1.02M
-36.44%-820.58K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
9.63%-646.97K
16.00%-601.4K
9.86%-641.79K
49.44%-2.79M
13.83%-647.43K
Noncontrolling interests
Net income attributable to the company
-56.99%-1.02M
-36.44%-820.58K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
9.63%-646.97K
16.00%-601.4K
9.86%-641.79K
49.44%-2.79M
13.83%-647.43K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-56.99%-1.02M
-36.44%-820.58K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
9.63%-646.97K
16.00%-601.4K
9.86%-641.79K
49.44%-2.79M
13.83%-647.43K
Diluted earnings per share
0.00%-0.01
0.00%-0.01
0.00%-0.01
0.00%-0.04
0.00%-0.01
0.00%-0.01
0.00%-0.01
0.00%-0.01
60.00%-0.04
-0.01
Basic earnings per share
0.00%-0.01
0.00%-0.01
0.00%-0.01
0.00%-0.04
0.00%-0.01
0.00%-0.01
0.00%-0.01
0.00%-0.01
60.00%-0.04
-0.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 60.47%947.21K29.22%755.97K6.92%690.07K-11.90%2.48M1.31%661.44K-18.85%590.27K-19.17%585.01K-9.55%645.39K13.87%2.82M-13.15%652.86K
Selling and administrative expenses 64.55%268.91K43.07%276.18K18.41%251.09K-6.66%810.42K55.96%241.93K-8.70%163.42K-30.63%193.04K-15.21%212.04K-10.66%868.28K-44.18%155.12K
-General and administrative expense 64.55%268.91K43.07%276.18K18.41%251.09K-6.66%810.42K55.96%241.93K-8.70%163.42K-30.63%193.04K-15.21%212.04K-10.66%868.28K-44.18%155.12K
Research and development costs 58.91%678.3K22.40%479.79K1.30%438.98K-14.24%1.67M-15.72%419.51K-22.16%426.85K-12.00%391.97K-6.50%433.34K29.74%1.95M5.05%497.74K
Operating profit -60.47%-947.21K-29.22%-755.97K-6.92%-690.07K11.90%-2.48M-1.31%-661.44K18.85%-590.27K19.17%-585.01K9.55%-645.39K-13.87%-2.82M13.15%-652.86K
Net non-operating interest income (expenses) -19.94%-67.99K-321.08%-64.39K-1,605.63%-61.26K-556.02%-128.94K-948.55%-61.04K-641.16%-56.68K-301.41%-15.29K34.91%4.07K231.13%28.28K153.63%7.19K
Non-operating interest income --0-73.37%1.84K-2.14%3.98K-20.88%22.37K-44.71%3.98K-29.11%7.43K-9.13%6.9K34.91%4.07K231.13%28.28K153.63%7.19K
Non-operating interest expense 6.05%67.99K198.44%66.22K--65.25K--151.31K--65.01K--64.11K--22.19K--0--0--0
Other net income (expenses) -2,389.47%-47379.77%-224-121.61%-1.05K7.14%-1.89K83.69%-287-101.91%-19-809.62%-1.11K66.81%-47299.93%-2.03K29.12%-1.76K
Gain on sale of security -2,389.47%-47379.77%-224-121.61%-1.05K7.14%-1.89K83.69%-287-101.91%-19-809.62%-1.11K66.81%-47245.74%-2.03K29.12%-1.76K
Income before tax -56.99%-1.02M-36.44%-820.58K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K9.63%-646.97K16.00%-601.4K9.86%-641.79K49.44%-2.79M13.83%-647.43K
Income tax
Earnings from equity interest net of tax
Net income -56.99%-1.02M-36.44%-820.58K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K9.63%-646.97K16.00%-601.4K9.86%-641.79K49.44%-2.79M13.83%-647.43K
Net income continuous operations -56.99%-1.02M-36.44%-820.58K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K9.63%-646.97K16.00%-601.4K9.86%-641.79K49.44%-2.79M13.83%-647.43K
Noncontrolling interests
Net income attributable to the company -56.99%-1.02M-36.44%-820.58K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K9.63%-646.97K16.00%-601.4K9.86%-641.79K49.44%-2.79M13.83%-647.43K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -56.99%-1.02M-36.44%-820.58K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K9.63%-646.97K16.00%-601.4K9.86%-641.79K49.44%-2.79M13.83%-647.43K
Diluted earnings per share 0.00%-0.010.00%-0.010.00%-0.010.00%-0.040.00%-0.010.00%-0.010.00%-0.010.00%-0.0160.00%-0.04-0.01
Basic earnings per share 0.00%-0.010.00%-0.010.00%-0.010.00%-0.040.00%-0.010.00%-0.010.00%-0.010.00%-0.0160.00%-0.04-0.01
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.